Skip to content

Study on the treatment scheme and neuroendocrine immune mechanism of children with ARDS

Study on the treatment scheme and neuroendocrine immune mechanism of children with ARDS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017749
Enrollment
Unknown
Registered
2018-08-12
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory distress

Interventions

Group 2:routine therapy + small dose methylprednisolone
Group 3:Routine treatment + blood purification

Sponsors

Fujian Provincial Maternity and Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 14 Years

Inclusion criteria

Inclusion criteria: 1. A known clinical manifestation within 7 days; 2. Respiratory failure that can not be completely explained by exhaustion or fluid overload; 3. New exudative changes in chest imaging are consistent with acute organic lung injury; 4. In non-invasive mechanical ventilation, mask BiPAP or CPAP is not less than 5cmH2O, P/F is not more than 300; 5. In invasive mechanical ventilation, the oxygenation index is more than 4.

Exclusion criteria

Exclusion criteria: 1. Pediatric patients with perinatal related lung disease; 2. Children with primary or secondary immunodeficiency or who are using immunosuppressive agents; 3. Children with congenital heart disease or dysplasia of the respiratory tract or abnormal development of the chest; 4. Children with malignant tumor and chronic kidney disease; 5. Children with active tuberculosis infection; 6. Children with severe malnutrition.

Design outcomes

Primary

MeasureTime frame
Time of PaO2/FiO2 more than 300 or oxygen timeindex less than 4;Mechanical ventilation time;Survival situation;Peripheral blood lymphocyte subgroup;IL-6;ACTH;cortisol;SP-D;IL-10;Ang-2;

Secondary

MeasureTime frame
Time to live in PICU;Time of hospitalization;Peptic ulcer bleeding in digestive tract;Hyperglycemia;Double infection;

Countries

China

Contacts

Public ContactLin Hai

Fujian Provincial Maternity and Children's Hospital

linhai652@163.com+86 18050303502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026